Discovery and Research

Uncovering Genomic Evidence of SARS-CoV-2 Infection and Reinfection

330 views
June 17, 2021
Is it possible to become reinfected with SARS-CoV-2? If so, how can we identify and confirm reinfection? What tools can we use to better identify prevalent and emerging strains of SARS-CoV-2?

Joel Sevinsky, Principal at Theiagen Consulting, is an expert in bioinformatics in the public health space and coauthor of a recent paper exploring the genomics evidence for reinfection with SARS-CoV-2 that was published in The Lancet Infectious Diseases. In this webinar, Dr. Sevinsky will discuss:

How next-generation sequencing (NGS) and off-the-shelf software confirmed the first documented SARS-CoV-2 reinfection case in the United States;

How bioinformatics analysis strongly supports the hypothesis that the patient was infected on two separate occasions by genetically distinct viruses;

The rationale for the continued use of NGS-based approaches for analysis and surveillance of SARS-CoV-2 samples.

Leif Schauser, Global Product Manager at Qiagen Digital Insights, will discuss recent product developments at Qiagen that support the detection, NGS analysis, and interpretation SARS-CoV-2-positive samples, including stain typing. He will discuss solutions that range from Qiagen cloud-based services to scalable applications for on-premises analyses.

Related videos

Discovery and Research

Exploring IPA’s Analysis Match: An Overview

5,431 views November 07, 2018

Learn about the new Analysis Match features and discover a new way to explore...

QIAGEN CLC Genomics

QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis

4,939 views January 28, 2020

In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...

Discovery and Research

CLC Genomics Workbench 12

2,802 views November 27, 2018

Introducing CLC Genomics Workbench 12 – an exciting new release that’s making...